| Product NDC: | 0187-1704 |
| Proprietary Name: | Mephyton |
| Non Proprietary Name: | phytonadione |
| Active Ingredient(s): | 5 mg/1 & nbsp; phytonadione |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0187-1704 |
| Labeler Name: | Valeant Pharmaceuticals North America LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA010104 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130319 |
| Package NDC: | 0187-1704-05 |
| Package Description: | 1 BOTTLE in 1 CARTON (0187-1704-05) > 100 TABLET in 1 BOTTLE |
| NDC Code | 0187-1704-05 |
| Proprietary Name | Mephyton |
| Package Description | 1 BOTTLE in 1 CARTON (0187-1704-05) > 100 TABLET in 1 BOTTLE |
| Product NDC | 0187-1704 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | phytonadione |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20130319 |
| Marketing Category Name | NDA |
| Labeler Name | Valeant Pharmaceuticals North America LLC |
| Substance Name | PHYTONADIONE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Increased Prothrombin Activity [PE],Reversed Anticoagulation Activity [PE],Vitamin K [Chemical/Ingredient],Vitamin K [EPC],Warfarin Reversal Agent [EPC] |